Table 4.
Conditions | Total sample
|
Total samplea
|
IBD statusa
|
Currently seeking treatmenta
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | Active | N | Remission | N | Yes | N | No | |
Panic disorder | ||||||||||||
Yes | 3 | 3.7% | 3 | 3.7% | 3 | 4.6% | 0 | 0% | 3 | 17.6% | 0 | 0% |
No | 78 | 96.3% | 78 | 96.3% | 62 | 95.4% | 16 | 100% | 14 | 82.4% | 64 | 100% |
Panic disorder (current) | ||||||||||||
Yes | 1 | 1.2% | 1 | 1.2% | 1 | 1.5% | 0 | 0% | 1 | 5.9% | 0 | 0% |
No | 80 | 98.8% | 80 | 98.8% | 64 | 98.5% | 16 | 100% | 16 | 94.1% | 64 | 100% |
Panic disorder (lifetime) | ||||||||||||
Yes | 2 | 2.5% | 2 | 2.5% | 2 | 3.1% | 0 | 0% | 2 | 11.8% | 0 | 0% |
No | 79 | 97.5% | 79 | 97.5% | 63 | 96.9% | 16 | 100% | 15 | 88.2% | 64 | 100% |
Social anxiety disorder | ||||||||||||
Yes | 6 | 7.4% | 6 | 7.4% | 6 | 9.2% | 0 | 0% | 3 | 17.6% | 3 | 4.7% |
No | 75 | 92.6% | 75 | 92.6% | 59 | 90.8% | 16 | 100% | 14 | 82.4% | 61 | 95.3% |
Generalized anxiety disorder | ||||||||||||
Yes | 12 | 14.8% | 9 | 11.1% | 11 | 16.9% | 0 | 0% | 5 | 29.4% | 7 | 10.9% |
No | 69 | 85.2% | 72 | 88.9% | 54 | 83.1% | 16 | 100% | 12 | 70.6% | 57 | 85.2% |
Obsessive compulsive disorder | ||||||||||||
Yes | 6 | 7.4% | 5 | 6.2% | 5 | 7.7% | 0 | 0% | 3 | 17.6% | 3 | 4.7% |
No | 75 | 92.6% | 76 | 93.8% | 60 | 92.3% | 16 | 100% | 14 | 82.4% | 61 | 95.3% |
Post-traumatic stress disorder | ||||||||||||
Yes | 3 | 3.7% | 3 | 3.7% | 3 | 4.6% | 0 | 0% | 2 | 11.8% | 1 | 1.6% |
No | 78 | 96.3% | 78 | 96.3% | 62 | 95.4% | 16 | 100% | 15 | 88.2% | 63 | 98.4% |
Anxiety disorder present | ||||||||||||
Yes | 19 | 23.5% | 16 | 19.8% | 16 | 24.6% | 0 | 0% | 8 | 47.1% | 8 | 12.5% |
No | 62 | 74.1% | 65 | 80.2% | 49 | 75.4% | 16 | 100% | 9 | 52.9% | 56 | 87.5% |
Note:
Based on participates meeting MINI DSM criteria and a HADS-anxiety subscale score >8.
Abbreviations: IBD, inflammatory bowel disease; MINI, Mini-International Neuropsychiatric Interview; DSM, Diagnostic and Statistical Manual; HADS, Hospital Anxiety and Depression Scale.